Tectonic Therapeutic (TECX) Exchange Rate Effect (2023 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Exchange Rate Effect of $94000.0 for Q1 2026, up 1980.0% year-over-year from $4519.2 in Q1 2025, and up 368.57% quarter-over-quarter from -$35000.0 in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Exchange Rate Effect for 4 consecutive years, with $94000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 1980.0% year-over-year to $94000.0; the TTM figure through Mar 2026 stood at $4000.0 (down 93.65% YoY), while the FY2025 annual figure was -$95000.0, down 1087.5% from the prior year.
- Exchange Rate Effect advanced to $94000.0 in Q1 2026 per TECX's latest filing, from -$35000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $94000.0 in Q1 2026 and bottomed at -$76000.0 in Q1 2024.
- Historically, Exchange Rate Effect has averaged $700.0 across 4 years, with a median of $5000.0 in 2024.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect plunged 300.0% — and 2026, when it jumped 1980.0%.
- Tectonic Therapeutic's Exchange Rate Effect stood at $16000.0 in 2023, then soared by 131.25% to $37000.0 in 2024, then slumped by 194.59% to -$35000.0 in 2025, then surged by 368.57% to $94000.0 in 2026.
- Business Quant data shows TECX's Exchange Rate Effect at $94000.0 in Q1 2026, -$35000.0 in Q4 2025, and -$23000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | 2,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Mar 31, 2026 | 94,000.00 |
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | -23,000.00 |
| Jun 30, 2025 | -32,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | 37,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | -76,000.00 |
| Dec 31, 2023 | 16,000.00 |